Literature DB >> 2215247

Thrombin stimulates the production of immunoreactive endothelin-1 in cultured human umbilical vein endothelial cells.

M Kohno1, K Yasunari, K Yokokawa, K Murakawa, T Horio, Y Kanayama, M Fuzisawa, T Inoue, T Takeda.   

Abstract

The present study was designed to examine the effect of thrombin on endothelin production by cultured human umbilical vein endothelial cells (HUVEC) by radioimmunoassay. Cultured HUVEC released immunoreactive endothelin-1 (ir-endothelin-1) into the medium in a time-dependent manner. This release was inhibited completely by 10 micrograms/mL cycloheximide and is, therefore, directly related to de novo protein synthesis. Further endothelin release was stimulated by the addition of thrombin to the culture medium. Thrombin-induced ir-endothelin-1 release also was inhibited completely by 10 micrograms/mL cycloheximide. These results suggest that HUVEC in culture produce ir-endothelin-1 slowly, but continuously, and that this production is stimulated by thrombin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2215247     DOI: 10.1016/0026-0495(90)90157-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Plasma endothelin-1 concentrations in patients with retinal vein occlusions.

Authors:  A Iannaccone; C Letizia; S Pazzaglia; E M Vingolo; G Clemente; M R Pannarale
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

2.  The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture.

Authors:  D G White; J W Mundin; M J Sumner; I S Watts
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

3.  The influence of endothelin-1 on human foeto-placental blood vessels: a comparison with 5-hydroxytryptamine.

Authors:  M R MacLean; A G Templeton; J C McGrath
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.